# Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients

Study · id `cardio:ct-nct01768208` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01768208](<https://clinicaltrials.gov/study/NCT01768208>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01768208

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 569 participants.

## Technical summary

Registry record NCT01768208. Allocation not applicable; no masking. Start 2012-10 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking
- Phase: Phase 4
- Enrolled: 569 participants (enrolled count; ClinicalTrials.gov record NCT01768208, source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01768208, source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT01768208, source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT01768208, source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01768208, source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01768208-2016-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
- Condition: Type 2 Diabetes
- Intervention (Drug): Saxagliptin
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

## Provenance

Content hash: 78c66dfb370f4cdf01dece41ba8bca8967584493f50529cdc498667f25741b8d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
